Observational Study on Safety and Efficacy in Subjects Using NovoMix 70 [Insulin aspart/insulin protamine aspart] (Biphasic Insulin Aspart) for Treatment of Type 2 Diabetes Mellitus.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 09 Aug 2014

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

15 Oct 2009 Actual end date changed from 581 to 590 as reported by ClinicalTrials.gov.
06 Nov 2008 Actual patient number (581) added as reported by ClinicalTrials.gov.
06 Nov 2008 Trial end date changed from Sep 2008 to Oct 2008 as reported by Clinicaltrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com